Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (TA275)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 2 July 2021Published: 27 February 2013
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation (TA249)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 2 July 2021Published: 15 March 2012
Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (TA355)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 2 July 2021Published: 23 September 2015
Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation (TA256)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 2 July 2021Published: 23 May 2012
Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism (TA354)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 August 2015
Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism (TA341)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 4 June 2015
Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism (TA327)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 17 December 2014
Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism (TA287)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 June 2013
Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism (TA261)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 July 2012
Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults (TA245)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 January 2012
Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults (TA170)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 April 2009
Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults (TA157)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 September 2008